儿童青少年注意缺陷多动障碍的非药物干预
全球约5%的儿童青少年受注意缺陷多动障碍(ADHD)影响,该综述更新评估了九类非药物干预的疗效与安全性。与药物不同,没有非药物干预对ADHD核心症状显示一致强效;多组分(认知)行为治疗在广泛结局上与药物并列为ADHD主要治疗。
要点
- 没有非药物干预对ADHD症状显示一致强效,但多组分(认知)行为治疗在广泛结局上与药物并列为一线治疗。
- 多不饱和脂肪酸连续服用至少3个月对ADHD症状有一致的中度效果。
- 正念与含四种或以上成分的多营养素补充对非症状结局有中度疗效,其余非药物干预安全但未证实相对其他治疗的疗效。
核心结论
- 没有非药物干预对ADHD症状显示一致强效,但多组分(认知)行为治疗在广泛结局上与药物并列为ADHD主要治疗。
研究设计与样本
- 本文为综述,更新评估了九类非药物干预治疗儿童青少年ADHD的疗效与安全性,并讨论其证据质量和级别。
主要发现
- 多不饱和脂肪酸连续服用至少3个月对ADHD症状显示一致的中度效果。
- 正念与含四种或以上成分的多营养素补充对非症状结局显示中度疗效。
- 其他所有非药物干预均安全,但未证实相对其他治疗的疗效。
关键数值与推荐
- 全球约5%的儿童青少年受ADHD影响。
- 多不饱和脂肪酸需连续服用至少3个月才显示一致的中度症状效果。
- 多营养素补充需含四种或以上成分才对非症状结局显示中度疗效。
临床怎么用
- 临床可将多组分(认知)行为治疗与药物并列为ADHD主要治疗,并在广泛结局上评估其获益。
- 对多不饱和脂肪酸(至少3个月)及正念、多营养素补充可考虑用于相应结局,但需向家庭说明费用、负担及疗效未证实等缺点。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Attention-deficit hyperactivity disorder (ADHD) affects approximately 5% of children and adolescents globally and is associated with negative life outcomes and socioeconomic costs. First-generation ADHD treatments were predominantly pharmacological; however, increased understanding of biological, psychological, and environmental factors contributing to ADHD has expanded non-pharmacological treatment possibilities. This Review provides an updated evaluation of the efficacy and safety of non-pharmacological treatments for paediatric ADHD, discussing the quality and level of evidence for nine intervention categories. Unlike medication, no non-pharmacological treatments showed a consistent strong effect on ADHD symptoms. When considering broad outcomes (eg, impairment, caregiver stress, and behavioural improvement), multicomponent (cognitive) behaviour therapy joined medication as a primary ADHD treatment. With respect to secondary treatments, polyunsaturated fatty acids showed a consistent modest effect on ADHD symptoms when taken for at least 3 months. Additionally, mindfulness and multinutrient supplementation with four or more ingredients showed modest efficacy on non-symptom outcomes. All other non-pharmacological treatments were safe; clinicians might tolerate their use but should educate families of childrenand adolescents with ADHD on the disadvantages, including costs, burden to the service user, absence of proven efficacy relative to other treatments, and delay of proven treatment.
引用
- Sibley MH, Bruton AM, Zhao X, et al. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023. PMID: 36907194. doi:10.1016/S2352-4642(22)00381-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。